F10 rs121964939: Understanding Factor X Deficiency Variants
The rs121964939 variant is a specific genetic change located within the F10 gene. It is associated with factor X deficiency, a rare inherited condition that impairs the body's ability to form blood clots effectively.
What each genotype means
Typical factor X function
This genotype represents the most common genetic sequence for this location in the F10 gene. Individuals with this profile do not carry the specific variant associated with hereditary factor X deficiency at this site.
This is the most common genotype found in the general population.
Carrier of factor X variant
You carry one copy of the variant associated with factor X deficiency. Because this condition is typically inherited in an autosomal recessive pattern, carriers usually do not exhibit symptoms of the disorder, though you should discuss your status with a healthcare provider if you have a family history of bleeding issues.
This genotype is rare in the general population, as factor X deficiency is an uncommon inherited condition.
Potential factor X deficiency
You carry two copies of this variant, which is associated with hereditary factor X deficiency. This condition can lead to impaired blood coagulation and variable hemorrhagic severity; please consult with a hematologist or medical professional to discuss what this means for your health and coagulation profile.
This genotype is extremely rare, consistent with the low prevalence of congenital factor X deficiency in the general population.
Understanding the F10 Gene
The F10 gene provides the essential instructions for the body to produce a protein known as coagulation factor X. This protein is a critical component of the coagulation system, a complex series of chemical reactions that occur after an injury to stop bleeding. When a blood vessel is damaged, factor X is activated and works in concert with other clotting factors to convert prothrombin into thrombin. Thrombin then acts on fibrinogen to create fibrin, the structural material that forms a stable blood clot. Because this process is vital for preventing excessive blood loss, any significant disruption in the production or function of factor X can lead to a bleeding disorder. The F10 gene is located on chromosome 13 and consists of eight exons that encode the instructions for this protein.
What is the rs121964939 Variant?
The rs121964939 variant is a specific alteration in the DNA sequence of the F10 gene. In the context of genetic research, variants like this are studied to determine how they impact the structure or expression of the resulting factor X protein. When a variant occurs in a gene responsible for a critical physiological process, it may lead to a reduction in the amount of functional protein produced or result in a protein that does not work correctly. Research into rs121964939 focuses on its role in hereditary factor X deficiency, a condition characterized by a spectrum of bleeding symptoms. Because this condition is typically inherited in an autosomal recessive pattern, individuals usually need to inherit the variant from both parents to experience significant clinical symptoms, though the severity can vary widely between individuals.
Research and Clinical Associations
Scientific literature identifies factor X deficiency as a rare bleeding disorder, representing approximately 10% of all rare coagulation defects. Research indicates that over 100 different mutations in the F10 gene have been linked to this condition. The evidence for specific variants like rs121964939 is often derived from clinical case studies where individuals present with symptoms such as easy bruising, nosebleeds, or prolonged bleeding after surgery. While the association between F10 variants and factor X deficiency is well-established, the clinical impact of any single variant can be influenced by other genetic and environmental factors. It is important to note that having a variant does not automatically guarantee a specific health outcome, as the body often has compensatory mechanisms. Clinical diagnosis of factor X deficiency is based on laboratory tests measuring prothrombin time and activated partial thromboplastin time, rather than genetic testing alone.
Population Frequency and Prevalence
Factor X deficiency is considered a very rare condition, with some estimates suggesting it affects approximately 1 in every 1,000,000 people globally. Because the condition is rare, the specific variant rs121964939 is also found at a very low frequency in the general population. Genetic databases often categorize such variants as rare or ultra-rare, meaning they are not commonly observed in large-scale genomic studies of diverse populations. The rarity of this variant means that there is limited data regarding its distribution across different ancestral groups. When a condition is this uncommon, researchers often rely on data from families with a known history of bleeding disorders to understand the variant's impact. If you have concerns about your genetic profile or family history of bleeding, it is essential to consult with a medical professional or a genetic counselor who can provide context based on your specific health history.
Managing Genetic Information
Genetic information regarding variants like rs121964939 is primarily used for research and clinical diagnostic purposes. If you have received information about this variant, it is important to understand that it is not a medical diagnosis. Genetic testing results should always be interpreted by a qualified healthcare provider who can correlate the findings with your physical symptoms, family history, and blood coagulation laboratory tests. You cannot use this information to self-diagnose or determine your risk for bleeding complications without professional guidance. If you are concerned about your clotting ability or have a history of unusual bleeding, speak with your doctor about appropriate screening tests. Never make changes to your health management or medication regimen based on genetic data without first discussing it with your clinician or a pharmacist, as they are best equipped to provide personalized medical advice.
How common is this variant?
The rs121964939 variant is rare in the general population, consistent with the rarity of hereditary factor X deficiency.
Frequently asked questions
What is factor X deficiency?
Factor X deficiency is a rare inherited bleeding disorder caused by mutations in the F10 gene. It results in a shortage or dysfunction of the factor X protein, which is necessary for blood to clot properly.
Can I be tested for the rs121964939 variant?
Yes, this variant can be identified through genetic testing. However, such testing is usually performed in a clinical setting when a doctor suspects a bleeding disorder based on symptoms or family history.
Does having this variant mean I have a bleeding disorder?
Not necessarily. Genetic variants are only one piece of the puzzle, and clinical diagnosis requires blood tests to measure actual clotting factor activity. Always consult a healthcare provider to interpret genetic results.
Is there a cure for factor X deficiency?
There is no cure, but the condition is managed with treatments such as plasma-derived factor X concentrates. These treatments help replace the missing protein to prevent or stop bleeding episodes.
Sources & further reading
Educational information only, last refreshed 10/1/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs121964939?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29